Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Cancers, Free Full-Text

Extracellular matrix and its therapeutic potential for cancer treatment

WO2016087994A1 - Btk inhibitors to treat solid tumors through modulation of the tumor microenvironment - Google Patents

The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers - Ren - 2023 - MedComm - Wiley Online Library

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

Biomedicines, Free Full-Text

Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets, Journal of Hematology & Oncology

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective

Frontiers Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components